Combinations of bHLH factors dimers generate great functional diversity required for cell type specification in development. The bHLH factor TWIST1 plays pleiotropic roles in craniofacial development. However, which combination of TWIST1 dimers are involved in craniofacial development, and what impact each dimer impose on gene regulation network remained elusive. Proteome profiling of human-TWIST1 expressing cell lines and transcriptome analysis of mouse cranial mesenchyme revealed TWIST1 homodimer and heterodimers with TCF3, TCF4 and TCF12 E-proteins as preferred combinations. We found that balance of homo-and heterodimers were impaired by human disease mutations in TWIST1 Helix domains, which may underpin the developmental defects in haploinsufficiency. Further, loss or gain of function analysis of TWIST1-E-protein dimers in differentiating embryonic stem cells revealed their previously unappreciated roles in lineage specification. TWIST1-E-protein heterodimers activate mesoderm and neural crest differentiation through epithelial-to-mesenchymal transition, whilst TWIST1 homodimers maintained a progenitor-like state and blocked entry to endoderm lineages.
Introduction
The basic helix-loop-helix (bHLH) superfamily is an evolutionarily conserved group of transcription factors required for lineage differentiation and early organogenesis. Through dimerization with different partner proteins, bHLH factors drive the specification of a plethora of cell types during neurogenesis, haematopoiesis and myogenesis (Schlaeger et al., 2004; Belle and Zhuang, 2014; Comai and Tajbakhsh, 2014; Dennis et al., 2019) . Eukaryotic helix-loop-helix (HLH) factors can be classified based on their structural and functional attributes (Massari and Murre, 2000) . Class I, II and V factors are known to engage in homoand heterodimerization. Class I proteins, comprised of all E-proteins (e.g. E12/TCF3, HEB/TCF12 and E2-2/TCF4), are broadly expressed in various tissues (Wang and Baker, 2015) .
Class II proteins generally have restricted expression in specific cell lineages, for example, MyoD in myogenic cells, NeuroD in neurogenic cells and TWIST1 in the tissue mesenchyme (e.g. craniofacial and limb mesenchyme) (Thisse et al., 1987; Lee et al., 1995; Spicer et al., 1996; Ghouzzi et al., 2000; Bildsoe et al., 2009; Bildsoe et al., 2013; Bildsoe et al., 2016) . Class V represents a group of non-DNA binding HLH proteins, such as IDs, that competes for Eprotein binding (Benezra et al., 1990) . It was hypothesised that the bHLH dimer composition is balanced by the expression level of bHLH factors, competition between them, and phosphoregulation (Centonze et al., 2004; Firulli et al., 2005; Firulli et al., 2007) . However, the identity of dimer combinations and their specificity during development remained enigmatic.
The bHLH factor TWIST1, highly expressed in cranial mesoderm-and neural crest-derived mesenchyme (Brault et al., 2001; Bildsoe et al., 2009; Bildsoe et al., 2013) , is critical for craniofacial development. Twist1 +/mice display craniosynostosis (Carver et al., 2002; Connerney et al., 2006) that partly phenocopies skeletal defects associated with TWIST1 haploinsufficiency in Saethre-Chotzen Syndrome (SCS, AHC [MIM: 101400] ). Conditional ablation of Twist1 from the cranial mesoderm or the cranial neural crest leads to malformations of the cranium, brain, cranial nerves, facial skeleton and muscles (Bildsoe et al., 2013) (Chen and Behringer, 1995 Soo et al; Ota et al., 2004) . At cellular level, Twist1 is required for maintaining the mesenchymal potency of progenitor cells for osteo-, chondro-, and adipogenic tissues (Brault et al., 2001; Bildsoe et al., 2009; Miraoui et al., 2010; Bildsoe et al., 2013) . Twist1 deficient craniofacial tissues surrounding midbrain and hindbrain acquire atypical epithelial features whilst losing mesenchymal features (Brault et al., 2001; Bildsoe et al., 2009; Miraoui et al., 2010; Bildsoe et al., 2013) . Previous studies highlight the differential functions of TWIST1 dimers in the osteogenic differentiation of the cranial sutural mesenchyme (Connerney et al., 2006; Connerney et al., 2008) , which is mediated by their targeted action on FGF signalling (Guenou et al., 2005; Rice, 2005; Miraoui et al., 2010) . For example, the TWIST1-TCF3 heterodimer promotes mesenchymal expansion, while TWIST1homodimer activates FGFR, OCN and BSP expression for ossification. Identifying TWIST1 dimerization partners and their transcriptional targets in the cranial mesenchyme, is therefore likely to allow for a better understanding of TWIST1 function during early development.
In this study, dimerization partners of TWIST1 were identified by mass-spectrometry analysis of TWIST1-containing complexes immunoprecipitated from human-TWIST1 (hTWIST1) expressing mesenchymal cells, in conjugation with Twist1 co-expression analysis in mouse embryonic head tissues. A bi-fluorescent complementation (BiFC) assay was used to elucidate the balance between hetero-and homo-dimerization and the impact of pathogenic mutations.
Finally, to delineate the immediate downstream targets and the function of TWIST1-dimers, we analysed differentiating ESC with Twist1 knockout mutations or TWIST1-E-protein inducible cassettes. Our results revealed a concert of TWIST1-dimers activities in mesoderm and neural crest determination and cellular behaviour: TWIST1-E-proteins heterodimers promote mesoderm and neural crest differentiation through epithelia-mesenchymal transition, whilst homodimer activity maintained a progenitor-like state and blocked entry to endoderm lineages. Taken together, our findings illuminated a previously unappreciated mechanism of specificity control in craniofacial development and disease, encoded by TWIST1 molecular interactions.
Results

Identification of dimerization partners of TWIST1 in embryonic head
Candidate dimerization factors were identified by their co-expression with Twist1 in the mouse embryonic head tissues. Microarray analysis of cranial neural crest cells (CNC, Wnt1-Cre active) and cranial mesoderm cells (CM, Mesp1-Cre active) revealed that 58 out of 158 known bHLH factors (Skinner et al., 2010) were expressed in the head mesenchyme Fan et al., 2016;  Supplemental Table S1 ). Twelve bHLH factors were significantly enriched in CNC or CM ( Fig. 1A) and forty-six were expressed in both tissues ( Supplemental   Table S1 ). Based on their known roles in craniofacial development, seven candidates were selected for validation, including SIM2, TCF4, EBF1, EBF3, TAL1, TWIST2, and TCF3 (isoform of E2A and a known TWIST1 partner as a positive control). HA-tagged protein constructs were transfected into Madin-Darby Canine Kidney (MDCK) cells that stably over-expressed hTWIST1 (designated as MDCK/hTWIST1-OE cells), which displayed TWIST1 induced mesenchymal phenotypes (Xue et al., 2012; Fig. 1B) . These factors were detected in complex with TWIST1 by co-immunoprecipitation using α-TWIST1 antibody. Reciprocally, TWIST1 was detected in together with HA-tagged EBF1, EBF3 and TCF4 in α-HA immunoprecipitated fraction ( Fig. 1B) , demonstrating interaction with the three bHLH partners. Genes encoding EBF1, EBF3 and TCF4 were co-expressed with Twist1 in the frontonasal tissues, the cranial mesoderm and the first branchial arch of the mouse embryo (Fig. 1C ).
Proteomic screening of MDCK/TWIST1-OE cells revealed TCF factors as the prevalent TWIST1 partners Further delineation of TWIST1 dimer partners was undertaken by unbiased proteomic screening by mass spectrometry following affinity purification of TWIST1-complexes from MDCK/hTWIST1-OE cells ( Fig. 2A ). Protein complexes were purified from lysate using α-TWIST1 antibody or mouse IgG (as the control) in triplicate. 846 proteins were identified and divided into three sets using the ranked-product method for differential analysis (Breitling et al., 2004) (Fig. 2B and Table S1 ). "Set 1" represented 103 identified proteins that specifically bound to TWIST1, "Set 2" were those proteins that bound specifically to IgG beads (377), while "Set 3" contained proteins bound both IgG beads and TWIST1 (362). As expected, TWIST1 was one of the top enriched proteins in "Set 1" (Fig. 2B ). Only two other bHLH factors, TCF12 and TCF4, were highly enriched, and the rest of "Set 1" putative partners included RNA-binding proteins and transcription factors such as Cyclin T2, TRIP6, GATA1, FHL2 and CRTC2 (Table S1 ).
Tcf4 and Tcf12, like Tcf3, were expressed in the facial primordia and overlapped with Twist1 expression domain in the frontonasal, the branchial arches and the mesoderm in embryonic head ( Fig. 2C ). We also demonstrated the interaction of TWIST1 with endogenous TCF4 and TCF12 in mouse embryoid bodies (EBs) overexpressing TWIST1 ( Fig. 2D ).
SCS mutations impair TWIST1-TCF12 dimer formation and function
The TWIST1 bHLH dimerisation domain shows 84-100% sequence identity among vertebrate orthologues (including human, mouse, frog and zebrafish). It is also highly conserved (~70%) among the TWIST1 family proteins: TWIST1, TWIST2, HAND and HAND2, reflecting functional conservation and significance (Castanon and Baylies, 2002; Qin et al., 2012) . There is a high incidence of 63 base clinically significant missense mutations in the bHLH domain, many of which are identified from SCS patients ( Fig. 3A ; Human genomic mutation database ; Stenson et al., 2003; Centonze et al., 2004; Firulli et al., 2005; Firulli et al., 2007; Barnes and Firulli, 2009 ) Some of these mutations are located directly at or around the threonine and serine phosphosites (Fig.3A) , and were found to inhibit TWIST1 phosphorylation (Firulli et al., 2005; Firulli and Conway, 2008) .
To validate the identified interactions and test the hypothesis that TWIST1 pathogenic mutations at bHLH region may shift the balance of homo-versus hetero-dimerization, we employed a multicolour BiFC assay (Hu and Kerppola, 2003) . It was previously shown that TWIST1 SCS mutations in the basic-helix I region, such as R118H, may impair phosphorylation at T121 and S123 residues, and alter the preference of dimerization with TCF3 and HAND2 (Firulli et al., 2005) . A subset of mutations in the basic-helix I region were selected (Fig.3A, red) : TWIST1(S123X) truncated at the bHLH, phosphorylation-inhibitory mutations (S123A and R118H) and phospho-mimetic mutations (T121E and S123E). We also selected previously uncharacterised residues on helix II that were conserved among TWIST-family members (T148A, A152P and I156N). When examined on a 3D reconstruction of TWIST1/TCF12 dimer (bHLH regions), the phospho-regulatory residues appeared to be in closer proximity to the DNA interface, rather than the site of E-protein interaction (Fig. 3Bi ). On other hand, clinical variants on helix II, affected residues at the protein interaction interface (Fig. 3 Bii) .
Since TCF12 is also associated with SCS and other craniofacial anomalies (Sharma et al., 2013) , we tested the impact of these mutations on TWIST1 dimerization with TCF12. TWIST1 and TCF12 were conjugated with different split fluorescent domains (N-or C-terminal) and coexpressed in C3H10T1/2 cells (Fig. 3C ). Using BiFC, we monitored dimerization of SCS mutant TWIST1 proteins with TCF12. The interaction of TCF12-CrN173 versus TWIST1-VN173 with TWIST1* mutant-or WT-CC155 was assessed by imaging the emission intensity of the two fluorophores ( Fig. 3C) . When expressed at similar levels, TWIST1 mutants displayed significant changes in their preference to form homo-(GFP) or heterodimers (CFP; Fig. 3D, E ). Amongst all mutations tested, truncation at the bHLH domain (S123X) most severely compromised dimerization ( Fig. 3D ). S123A and R118H, however, significantly increased the preference for heterodimer formation, compared to WT. In contrast, the phospho-mimetic form (TSE or T121E & S123E) of TWIST1 favoured homo-dimerization. All three mutations at helix II (in the C-Term region) were associated with reduced TWIST1/TCF12 and TWIST1/TWIST1 ratios and ( Fig. 3D ), and overall lower dimerization activity (Supplemental Fig. S1B ). Meanwhile, TWIST1 with a deletion of the N-term region did not affect dimer ratio (Supplemental Fig. S1A ).
Mutations associated with a significant shift in dimer balance were further tested for the impact on cell migration, a TWIST1-driven biological process. Scratch assay was performed on C3H10T1/2 cells co-transfected with Twist1*mutant-CC155 and Tcf12-CrN173 constructs expressing the recombinant proteins ( Fig. 3E ). Cells expressing TWIST1 with helix II mutations (A152P, I156N), showed reduced cell migration compared to TWIST1 wildtype/TCF12 expressing cells (Fig. 3F ). These results demonstrate that mutations in Helix II that severely disrupted TWIST1/TCF12 dimerization also impaired downstream function in mesenchymal cell migration.
Loss of Twist1 impairs ESC pluripotency exit and cell fate specification
We detected TWIST1 expression during the differentiation of ESCs, initially from Day 3 and peaking at Day 6-7 of differentiation ( Fig. 4A ). To examine TWIST1 functionality in differentiation, we generated mono-and bi-allelic Twist1 knockout mouse ESC cell lines using CRISPR-Cas9 technique (Fig. 4B, C) , and compared expression of pluripotency and lineage markers with the parental cell line on Day 3 of differentiation ( Fig. 4D-F ). Pairwise statistical tests revealed that both full and partial loss of Twist1 disrupted lineage specification in a gene dosage-dependent manner. Pluripotency genes such as Dppa2, Nanog, Sox2 and Pou5f1 retained expression at the pre-differentiated levels in the mutant cells, significantly higher than the Day-3 wildtype counterpart ( Fig. 4D ). Concurrently, ectodermal and mesodermal genes failed to be activated in the mutant cells ( Figure 4E , F). Expression of EMT genes, such as Flk1, Pdgfra, Snail2 and Vegfa were reduced, whilst the epithelial marker, Cdh1, was upregulated ( Fig. 4F ). In contrast, endodermal markers (such as Gsc, Rbm47, Foxa2) and WNT signalling components (such as WNT ligand Wnt3, receptors Fzd10 and Prickle1, target gene Axin2) were up-regulated in the mutant cells ( Fig. 4G , H). These findings implicated various roles of TWIST1, potentially attributable to different dimer-patterns, in the maintenance of the mesenchymal progenitor and selectively directing lineage differentiation of the embryonic stem cells.
Comparison of the target specificity of different TWIST1 dimers
To further elucidate the scope of TWIST1-dependent function in lineage differentiation, a gain of function approach was taken to analyse the downstream genes of the homodimer and heterodimers. We tethered TWIST1 and TCF proteins into dimers via flexible poly-glycine linkers and expressed these dimers in ESCs (Fig. 5A, B ). In Drosophila, tethered Twist-Twist and Twist-Dorsal dimers could recapitulate the function of dimers formed naturally by Twist1 and Dorsal; Twist homodimer induced Mef2 expression and muscle differentiation in vivo, whereas the Twist-Dorsal dimer antagonised this activity (Castanon and Baylies, 2002) .
Following the same principle, we constructed dimers for TWIST1 and E-proteins partners ( Fig.   3A ): TWIST1-TWIST1 (TT), TWIST1-TCF3 (T3), TWIST1-TCF4 (T4), TWIST1-TCF12 (T12) and TWIST1 monomers (T0). Coding sequences were stably integrated into the genome of A2LoxCre ESCs, downstream of a doxycycline inducible promotor (Iacovino et al., 2014) . ESCs were then differentiated for three days as EBs, and assayed for the expression of It was previously demonstrated by in vitro mobility shift assay that dimer formation alters DNA sequence specificity (Firulli et al., 2007; Chang et al., 2015) . Sequence motif analysis was performed on the promotors of dimer-specific DEGs. Top ranking regulatory motifs for the heterodimers comprised of canonical E-boxes "CATCTG" or "CAGCTG" (Fig. 6B ). TT targets were uniquely enriched in double E-boxes with a five nucleotide spacer, as reported in a ChIPseq study in human mammary epithelial cells over-expressing TWIST1 (Chang et al., 2015) .
Binding of the double E-box motif, found to this date only for Drosophila Twist and human hTWIST1, may suggest higher order tetramer formation between TWIST1 and E47 (a spliceoform of TCF3; Chang et al., 2015) . Our results showed that recognition of a double Ebox might be enhanced by the tethered TWIST1 homodimer. TWIST1 monomer recapitulated partially the activity of TT and T3 dimers, but also regulated a unique group of genes (177/336 upregulated and 87/218 down regulated). In consistence, the monomer showed reduced recognition of canonical E-boxes compared with the dimer counterparts, and were redirected to GATA motifs, suggesting additional co-factor binding.
To dissect the functionality of each dimer individually, we performed additional gene-set enrichment analysis based on gene expression values (see Methods). EBs expressing monomer or homodimers displayed repression of developmental gene-sets relative to the parental A2LoxCre cells (Supplemental Fig. S4A ; Supplemental Table S2 ). Differentiation of neural-ectoderm derivatives were repressed by the monomer (T0), and mesoderm and endoderm cell fates were repressed by TT. On the other hand, heterodimers activated overlapping sets of genes associated with mesoderm and neural ectoderm development (Supplemental Fig. S4A ; Supplemental Table S2 ). T3 dimer activated heart developmental processes, including heart vasculature, muscle, and blood cells, while the most frequent processes induced by T4 were related to neuron differentiation (Supplemental Fig. S4A ; Supplemental Table S2 ). T12 activity was intermediate between T3 and T4. A comparison down to specific cell lineage and pathway genes also reflected these changes ( Fig. 6C, D) .
Evident in the heterodimer groups, was the downregulation of pluripotency genes and a burst in cell lineage markers, especially those for mesoderm and neural crest development ( Fig. 6C ).
T3 dimer preferentially activated mesoderm markers, whilst T4 dimer favoured ectoderm and neural crest genes ( Fig. 6C ). Heterodimers also showed a stronger capacity to activate genes associated with EMT pathway (Supplemental Table S3 , Fig. 6D )
Taken together, our data demonstrated that TWIST1 dimerization partners drive different gene expression programs that may be influenced by the preference for specific DNA motifs.
Heterodimers appeared to drive neural and mesoderm differentiation, whereas the monomer or homodimer of TWIST1 repressed the expression of genes associated with endoderm differentiation.
TCF12-TWIST1 dimer activates EMT more robustly and antagonise TWIST1 homodimer activity for critical craniofacial pathway genes Given that the synergy between Twist1 and Tcf12 in normal cranial tissue development (Sharma et al., 2013) , we compared the ability of T12 and TT dimer to induce transcription of developmental pathways ( Supplemental Table S3 , Supplemental Fig. S4B , C). T12-expressing cells significantly activated more genes associated with TGFb signaling (FDR 0.007), WNT signaling (FDR 0.017) and EMT compared to TT (FDR 0.002; Fig. 7A ). Although both T12 and TT could promote the expression of EMT genes, around 50% of all EMT genes were enriched in T12 cells compared to TT (Fig. 7A ). T12 expressing cells were also enriched for genes associated with developmental processes of neuronal, skeletal, face and cardiovascular system development ( Fig. 7B, Supplemental Fig. S4B ). We then examined transcriptional regulators that has been previously associated with craniofacial development (Fig. 7B , Face development). As mentioned earlier, studies in the skull suture suggested that antagonistic regulation by the homo-and heterodimers (Connerney et al., 2006; Connerney et al., 2008) ,.
Indeed, we noted that a subset of critical developmental regulators, such as those associated with TGFb signaling (e.g. Tgfbr1, Pdgfra) and WNT (Prickle1, Dkk1) were antagonistically regulated by the homodimer and heterodimers ( Fig. 7C ). Most other genes, represented by Fgfr2, Jun, Chd7 and Mmp2 were activated to a greater extent by T12 than TT (Fig. 7C ). The differential expression of downstream genes between T12 and TT was likely to be the outcome of the balancing activity of these two forms of dimers in transcriptional regulation.
Discussion
TCF factors are the major dimerization partner of TWIST1
Our study identified TCF3, TCF4 and TCF12 E-proteins, which were expressed in cranial mesenchyme, as the predominant interacting partners of TWIST1. E-proteins partner with several other Class II bHLH factors (Forrest et al., 2014) . The three E-proteins also interacted with HAND2 (preferentially for TCF3) and shown to greatly enhance transcriptional activity in GAL4 reporter assays in yeast (Murakami et al., 2004) . Consistently, we find that TWIST1 activated ESC differentiation programs more robustly when coupled with E-proteins. Both HAND2 and TWIST1, when coupled to different E-proteins, also leads to altered E-box binding sequence specificity (Murakami et al., 2004; Firulli et al., 2007) . This altered sequence specificity is likely to underpin the regulation of the expression of different genes, leading to a mechanism whereby dimer combinations may target to developmental gene regulatory networks in specific cellular and timing context.
Molecular pathology of SCS mutations in context of bHLH factor dimerization
Dimerization is modulated by the availability of partner proteins, competing factors and the phosphorylation of the bHLH domain (Centonze et al., 2004; Firulli et al., 2005; Firulli et al., 2007) . Hypo-phosphorylation mutations (T121A, S123A) near or at the Helix I phosphorylation sites was previously shown to favour homodimerization (Firulli et al., 2005) . Yet a triple phospho-mutant model of TWIST1 (S123A, T148A and A184A) in oncogenic cell lines showed preference for dimerization with TCF3 and HAND2 compared to wildtype TWIST1 (Wang et al., 2017) . In line with this, we find that two individual hypo-phosphorylation mutants (R118H, S123A) both increased preference for TCF12 heterodimer formation, whilst phospho-mimetic forms at T121 and S123 reduced heterodimerization, compared to wildtype TWIST1. We note that incorporation of the negatively charged phosphate group to these residues may reduce binding to DNA, rather than directly interfering with the dimerization surface ( Figure 3B ). Therefore, T121/S123 dephosphorylated TWIST1 may favour heterodimerization through stabilising DNA-binding or adapting a helix conformation that enhances E-protein binding.
Mutations at TWIST1 Helix II compromised both types of dimerization. This impaired dimerization functionally impacts on the migration of mesenchymal cells, which was not encountered for variants near Helix I. Together, these conserved residues, in the context of their structural role in helix conformation, act as an important dimerization interface.
Our finding that TWIST1 SCS mutations disrupted the relative ratio of T12 and TT dimers may underpin the dysregulation of developmental genes in disease models. RNA-seq analysis in differentiating ESCs revealed that the TWIST1-TCF12 dimer was a potent driver of EMT and mesenchymal differentiation, compared to TWIST1 homodimer. T12 also induced signalling pathways and key transcription regulators associated with craniofacial development. These genes were either inactive or repressed in the homodimer expressing cells. The Twist1 heterozygous (Twist1 +/-) mouse model that recapitulates premature fusion of the suture displays excessive FGF and TGFb signalling at the osteogenic front to mid-suture mesenchyme, as revealed by the enhanced expression of FGFR2, pSmad 1/5/8, and ID proteins (Connerney et al., 2006; Connerney et al., 2008) . Our transcriptome analysis suggests that these molecular responses may be related to the enhanced activity of TWIST1-E-protein heterodimer. The Basic-Helix I mutations (R118H, S123A) could directly lead to increased heterodimer ratio. In contrast, the helix II variants generated dimerization-defective TWIST1 protein, leading to situation similar as haploinsufficiency. These findings support a defect-causing mechanism driven by bHLH haploinsufficiency.
Dimerization-dependent activities of TWIST1 in progenitor cell lineage specification TWIST1 regulates multiple pathways in linage specification in vitro. Loss of Twist1 function led to retention of pluripotency, defective mesoderm and ectoderm differentiation, as well as disrupted EMT process. EMT is tightly associated with ESC differentiation, especially the specification of mesoderm (Nakaya and Sheng, 2008; Evseenko et al., 2010; Iacovino et al., 2014) . Canonical WNT signaling directs ESC germ layer differentiatoin (Ten Berge et al., 2008) , and induces major EMT drivers including Twist1, Zeb2, Snail1 and Snail2. However, constitutive activation of WNT primes the differentiation of precursor cells towards primitive endoderm (Price et al., 2013) . Both Twist1 and Snail1 are required for WNT induced mesoderm differentiation (this study; Sharma et al., 2013) , but only Twist1 appeared to negatively feedback on WNT signaling regulation and repress endoderm cell fates. Overexpression of the TWIST1 homodimer blocked WNT activity and endoderm differentiation, whilst loss of TWIST1 shifted EBs towards endoderm. On the other hand, ablation of Snail1 promoted ectodermal fate instead of mesendoderm, without affecting WNT pathway genes (Sharma et al., 2013) . These observations suggested two arms of control by TWIST1; an EMTdependent role in promoting mesoderm and neural crest commitment, and an EMTindependent role in endodermal repression, potentially by negatively feedback on WNT activity.
These pleiotropic activities TWIST1 during lineage commitment were directed by E-proteins. E-proteins display overlapping expression patterns and developmental functions in embryonic tissues (Murakami et al., 2004; Wang and Baker, 2015) . They are expressed in the cranial mesenchyme and proliferating neuroepithelium in E9.5 -E11 mouse embryos (Murakami et al., 2004) . Tcf3 and Tcf12 expression are restricted in the proliferative ventricular and subventricular zones and are down-regulated during neurogenesis (Uittenbogaard and Chiaramello, 2002; Pfurr et al., 2017) . Tcf4 expression persists in the adult brain regions that overlaps with neuronal bHLH factors such as ATHO1, ASCl1 and NEUROG2, and initiates neuronal specification (Forrest et al., 2014) . Consistent with these findings, tethered TWIST1-TCF4 was found to modulate the activity of neural-ectoderm genes, whereas tethered TWIST1-TCF3 acted on the mesoderm genes. TWIST1-E-protein heterodimers activated the TGF-β signalling pathway and neural crest cell differentiation, and up-regulated ID proteins, which may provide a negative feedback mechanism to modulate the activity of the heterodimer (Connerney et al., 2006) .
In conclusion, our study uncovered patterns of TWIST1 dimerisation that offered additional controls in lineage differentiation. Our finding suggest that TWIST1 cooperates with TCF partners to promote the differentiation of neural crest and mesoderm, and represses endoderm as homodimers. Different heterodimers may fine tune mesenchyme precursors for myogenesis, skeletogenesis and neurogenesis fates. Our study also provided resource for the interpretation of results and controversies from TWIST1 over-expression systems, in which the phenotypic effect could be a net result of the action of homodimers and heterodimers. In the context of craniofacial morphogenesis, we showed that loss of function mutations of Twist1 may disrupt dimer balance, which may underpin the mesenchymal tissue defects and the aberrant neural crest cell development. Ultimately, using advanced molecular biology tools, this and future studies would shed light on precision control in complex developmental processes, through molecular information encoded and transmitted through protein interactions.
Materials and Methods
Cell culture
The Madin-Darby Canine Kidney (MDCK) cell line over expressing human TWIST1 was received from Xue and colleagues (Xue et al., 2012) . Cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM, Gibco), 10% Fetal calf serum (FCS) and 10 mM βmercaptoethanol at 37°C and 5% CO2. TWIST1 expression was constant selection using 4 μg/mL of puromycin (Xue et al., 2012) . C3H10T1/2 cell line was received from ATCC. Cells were maintained in high glucose DMEM with 10% FCS (Life Tech, Australia) and 10 mM β-mercaptoethanol at 37°C in 5% CO2. Both cell lines were typically split at ratio 1:6-1:10 to maintain desired density.
Mouse ESCs (A2loxCre) was a gift from Kyba Lab (Lillehei Heart Institute, Minnesota, USA), originally described in Mazzoni et al., (2011) incubated at room temperature for 15 mins (for nuclease activity). Equal volume of hypertonic lysis buffer (HEPES 20 mM, NaCl2 500 mM, MgCl2 1 mM, Glycerol 10%, DTT 1 mM, 1x Complete protease inhibitor) was applied to the lysate. Cells are further broken down by passage through gauge 25 needle for 10 strokes and rotated at 4°C for 30 min. After centrifugation at 14,000 x g, 15 min, 450 μl lysate were incubated with 5 ug a-TWIST1/ mouse IgG antibody at 4°C overnight with rotation. Meanwhile, Dynabead® protein G slurry (Invitrogen™, cat. 10003D) was prepared by washing and blocking for 1 hr at RT in 1% BSA 0.1% triton in PBS before use. 50 μl Dynabead was used for each treatment to capture antibody-protein complexes by rotating at RT for 30 mins. Beads were washed in 500 μl icecold wash buffer (1:1 mixture of the lysis buffer, without nuclease) for 6 times, and transferred to new 1.5 ml tube before the last wash. Beads were then washed quickly with cold 1 ml 50 mM Tris·HCl, pH 7.4, and then 500 μl TEAB (75 mM). Lastly, beads were collected after spinning down for 5 min at 2,000 × g, before processing for Mass-spectrometry analysis.
Tryptic digestion of bead-bound protein was performed by adding trypsin 1:20 (ug) of the sample directly onto the washed beads in 50mM TEAB buffer. After a brief vortex to resuspend the beads, they were incubated at 37 °C overnight. A second digest was performed by adding trypsin 1:40 to the sample the next morning, incubated for 4 more hours. The tubes were placed on a magnet to allow the beads to collect at the tube wall; the supernatant was removed and directly placed into TFA to give a final concentration of 0.5%.
Proteolytic peptides were desalted using Oligo R3 reversed phase resin (Thermo Fisher Scientific) in stage tips (Rappsilber et al., 2007) Using a reversed decoy database, a false discovery rate (FDR) threshold of 1% was used. The lists of protein groups were filtered for first hits.
Rank Product analysis for MS data
We generated three sets using the non-parametric rank product method (Breitling et al., 2004 ) based on how many times a protein was reported across independent experiments (Supplemental Table S4 ). If proteins were present in at least two Twist and two control samples, we deemed this set suitable for a two-class comparison, i.e. direct comparison of protein levels (set 1). To test for cases where proteins were preferentially detected (here "preferentially" is defined as present in at least 2 samples for Twist, i.e. Set 3, and 2 samples for Control, i.e. Set 2, and not detected in at least 2 samples of their respective contrast), we employed a single class test. The overall schema is represented in Fig. 2B and summarised below:
Set 1: present preferentially in IPs (n ≥ 2) Set 2: present preferentially in control IPs (n ≥ 2) Set 3: present in Twist and control cell IPs (n ≥ 2) P-values and FDR were then determined using the rank product method implemented in the RankProd R package (version 2.34) using 1000 permutations (Hong et al., 2006) . We used an FDR threshold of 0.20 in each set. If a protein for Set 1 was present in Sets 2 or 3 it was removed after FDR calculation.
Protein Immunoprecipitation
For the analysis of exogenous protein localisation, 3T3 cells were transfected 24 h before immunostaining using Lipofectamine® 3000 (Life Tech) according to manufacturer instructions with the following combinations of plasmids: pCMV-Twist1-FLAG plus one of (pCMV-gfp-HA, pCMV-Tcf3-HA, pCMV-Prrx1-HA, pCMV-Prrx2-HA, pCMV-Chd7-HA, pCMV-Chd8-HA, pCMV-Dvl1-HA, pCMV-Smarce1-HA, pCMV-Tfe3-HA, pCMV-Whsc1-HA, pCMV-
Hmg20a-HA)
Cell pellet were thawed in 300 μl hypotonic lysis buffer (HEPES 20 mM, MgCl2 1 mM, Glycerol 10%, Triton 0.5 %, DTT 1 mM, 1x Complete protease inhibitor [Roche], Benzo nuclease) and incubated at room temperature for 15 mins nucleic acid digestion. Equal volume of hypertonic lysis buffer (HEPES 20 mM, NaCl2 500 mM, MgCl2 1 mM, Glycerol 10%, DTT 1 mM, 1x Complete protease inhibitor) was applied to the lysate. Cells are further broken down by passage through gauge 25 needle for 10 strokes and rotated at 4°C for 30 min, and centrifuged at 14,000 x g for 15 min. The supernatant was incubated with a-TWIST1/ a-FLAG antibody (2 ug/ ml) at 4°C for 2 hrs. 1/10 volume of Protein-G agarose beads (Roche) was then added and the sample rotated for 30 min at RT °C. Beads were washed with ice-cold wash buffer (1:1 mixture of the two lysis buffers) for 6 times, and transferred to new 1.5 ml tube before eluted in 2x LDS loading buffer (Life Technologies) at 70°C for 10 mins. Half the eluate was loaded on SDS-PAGE with the "input" controls for western blot analysis.
Western Blotting
Protein was extracted using RIPA buffer lysis (1× PBS, 1.5% Triton X-100, 1% IGEPAL, 0.5% Sodium Deoxycholate, 0.1% SDS, 1 mM DTT, 1x Complete protease inhibitor [Roche]) for 30 minutes at 4°C under rotation. Lysed samples were then centrifuged at 15000 g and supernatant collected. Protein concentration was determined using Direct Detect spectrometer (Millipore). 20 µg of protein per sample was denatured at 70°C for 10 mins in 1× LDS loading buffer. Protein electrophoresis and transfer was performed using NuPage system (Life Technologies, Cat. NP0322BOX), following manufacturer instructions.
Membranes were revealed using SuperSignal West Pico PLUS (Thermo Scientific, Cat. #34580) as per manufacturer's protocol. Blots were imaged using ImageReader LAS 4000 (GE Healthcare Life Sciences).
Primary antibodies used were mouse monoclonal anti-TWIST1 (1:1000, abcam, Cat. #ab50887), mouse anti-α-tubulin (1:1000, Sigma, Cat. #T6199), rabbit anti-HA (1:1000, abcam, Cat. #ab9110) and mouse anti-FLAG M2 (Sigma, Cat. #F1804). Secondary antibodies used were HRP-conjugated donkey anti-Rabbit IgG (1:8000, Jackson Immunoresearch, Cat. #711-035-152) and HRP-conjugated donkey anti-Mouse IgG (1:8000, Jackson Immunoresearch, Cat. #711-035-150).
Generation of Twist1 mutant ESC by CRISPR-Cas9
ESC editing and selection by GFP was performed as described in detail in (Sibbritt et al., 2019) .
Briefly, 3µg of pSpCas9(BB)-2A-GFP (addgene plasmid #48138, a gift from Feng Zhang) containing the gRNA were electroporated into 1x106 A2loxCre ESCs using the Neon® Transfection System (Thermo Fisher Scientific). mESC colonies were picked by GFP expression on day 4 after electroporation.
For mESC genotyping, One-third of each dissociated clone was used to grow on gelatine coated plate for three passages, to remove residue MEFs contamination. Region surrounding the mutation site (+/-200 bp) was amplified from cell lysate and purified for sequencing.
Clones with potential bi-or mono-allelic frameshift mutations were expanded for further validation. Targeted genomic regions were again amplified and cloned into bacteria vector to identify mutations on each allele. Isogenic ESC clones with desired mutations were used for subsequent experiments.
Generation of dimer inducible ESC line
The inducible TWIST1-dimer ESC lines was generated using the inducible cassette exchange method described previously (Mazzoni et al., 2011) . The protein coding sequences were cloned from the mouse embryo cDNA library into the p2lox plasmid downstream of Flag-tag (Mazzoni et al., 2011) . Plasmid was transfected into A2loxCre treated with 1 μg/mL doxycycline for 24 hrs. Selection was performed in 300 μg/mL of G418 (Gibco) antibiotic for one week. Colonies were then picked and tested for TWIST1 expression following doxycycline treatment.
Embryoid body formation
Embryoid bodies (EB) were maintained in EB-medium consisting of high glucose DMEM supplemented with 15% heat-inactivated FCS, 1% Non-essential amino-acid supplement and 10 mM β-mercaptoethanol. Single ES cells were seeded onto aggrewells in a 24 well plate (Stem Cell Technologies, Cat. No. 34411) at 1.5 × 10^6 cells per well in EB-medium. Cell aggregates were transferred to non-tissue culture treated 10 cm plates and EB-medium 24 hrs later, and placed on an orbital-shaker under slight rotation at 37 °C, 5% CO2, to prevent single EBs from attaching to each other or surfaces. Drug treatment conditions was optimised as shown in Supplemental Fig. S2 . Doxycycline was supplied at 50 ng/ml for T3 and T12, 100 ng/ml for TT, and 1000 ng/ml for other cell lines 2 days in differentiation media. Cells were collected 16 hours later, as expression of known TWIST1 targets peaked 12-16 hrs after induction (Supplemental Fig. S2B ).
RNA-seq and data analysis
The raw RNA-seq sequence data were deposited into NCBI GEO database and can be accessed with the accession number GSE130252. Token for data access: elajseaoxnmbtwv RNA library prep (Truseq mRNA kit) and sequencing service (Hiseq2500, 100bpPE) was provided by Macrogen (Seoul, Korea). Raw Fastq sequence files (20 Million reads per sample) were imported into Galaxy instance (https://galaxy-mel.genome.edu.au/) from Macrogen Server and analysed using the following standard pipeline outlined in Fig. 4.8 (Anders et al., 2013) . FastQC package was used to assess data quality and adapter sequences and lowquality reads were trimmed from the original reads (Slidingwindow method in Trimmomatic package). A minimum of 50 bp read length filter was applied. Alignment was performed using Tophat2 package, against the built-in mm10 genome. The resulting bam file was sorted and assessed visually, before read was counted by htseq-count package, using Genecode mouse basic genome assembly (GRCm38, vM10).
Read count values were imported into R software for DEG analysis (Afgan et al., 2016;  Supplemental Fig. S3 ). Genes that are not expressed at a biologically meaningful level under any conditions were discarded. A standard count per million (CPM) reads value threshold of 1 (or log-CPM value of 0) was used for defining a gene to be expressed. To be kept for downstream analysis, a gene had to be expressed in at least three samples across the entire experiment. After filtering using this criterion, the number of genes was reduced to 14,165, approximately half the number that was started with. One replicate of T12 sample was removed from further analysis due to low library size. For EdgeR and limma-voom analysis, the data were normalised by library size before further processing.
Pre-processed data were analysed with three different R/Bioconductor packages: DESeq2, EdgeR and limma-voom (Robinson et al., 2010; Love et al., 2014; Ritchie et al., 2015) . For T12 and TT, more than 60% of total DEG were shared for all three methods (Supplemental Fig.   S3A ). However, when using the common adjusted P-value (adjp) threshold of 0.05, limmavoom generated the most stringent list while EdgeR gave the most permissive list (Supplemental Fig. S3 ). When -LOGadjp from different calculations are visualised on the scatter plot, DESeq2 and EdgeR had good correlation (R 2 = 0.79), while limma-voom tends to assign lower -LOGadjp values in pairwise comparisons (Supplemental Fig. S3B ). Based on these results, DESeq2 was used for further DEG analysis, which gave intermedium-range stringency.
Two types of gene-set analysis were performed: competitive gene-set analysis using Toppgene suite in Figure 5H , and self-contained gene-set analysis using ROAST package in Table S2 and summarised in Supplemental Fig. S4 Wu et al., 2010) . In contrast to commonly used competitive gene-set analysis, the self-contained test takes gene expression into account and examines whether the genes in the set/pathway are differentially expressed as a whole for different dimers. Motif analysis on DEGs was performed using Homer package (Heinz et al., 2010) .
Plasmid construction
Plasmids used in the BiFC experiments were generous gifts from Hu Lab, imported via Addgene depository. The plasmid backbone and the describing publication is listed in Table   S4 (Shyu et al., 2006) . Twist1 and Tcf12 were cloned from cDNA library generated from mouse head (Embryonic day 9.5), and inserted into relevant plasmids. Mouse homologous of S123A, R118H, T121E; S123E, T148A, A152P and I156N variants were generated by site-directed mutagenesis, using primers listed in Supplemental Table S5 .
Bi-Fluorescent Complementation (BiFC) Experiments
BiFC experiments and quantitative analysis were performed as described previously (Hu and Kerppola, 2003) . The day before transfection, C3H10T1/2 cells were seeded on to 0.1% gelatine coated coverslips, at a density of 1.66x 10^6 per 9.6 cm 2 (6-well). 24 hours later, transient transfection was performed using Lipofectamine 3000 (Life Technologies) according to manufacturer's instructions. Plasmid encoding TWIST1-VN173, TCF12-CrN173 were cotransfected with wildtype or mutant TWIST1-CC155 (Fig. S1A ) at 1 µg each.
Cells were imaged 16-24 hours following the transfection. Before imaging, they were brought to room temperature, washed twice with PBS and fixed in 4% PFA for 10 mins. Coverslips were then washed three times in PBT (1% Tween 20 in PBS), once in 1% Trition X-100 in PBS for 5 minutes, and three times in PBT. This was followed by incubation with 4',6-diamidino-2phenylindole (DAPI; Sigma-Aldrich; 1:10000) for 10 mins at room temperature. Coverslips were washed three times in PBT for 5-minute incubation in dark conditions, mounted using Fluoromount-G (Invitrogen) and stored at 4°C.
All immunofluorescence slides were imaged using Zeiss Axio Imager A1 (Carl Zeiss, Australia). TWIST1*-CC155/ TCF12-CrN173 heterodimers were visualized using a CFP filter set. A GFP filter set was used for detection of TWIST1*-CC155/ TWIST1-VN173 homodimers and DAPI was imaged at 405 nm. For BiFC quantification, images were taken across the slides with randomised pattern, at 20 x magnification. At least 1000 cells from each treatment (based on DAPI counting) were sampled across three biological replicates. Fluorescence intensity from the nucleus (DAPI stained) was quantified using ImageJ software and analysed in R (codes are available upon request).
After filtering for background fluorescent, using the same intensity threshold for all treatment groups, the ratio between CFP/ GFP was taken for each cell. And mean value of this ratio was used to compare the CC155/ CrN173 and CC155/ VN173 dimer formation efficiency between wildtype or mutant TWIST1. Non-parametric Mann-Whitney U Test was used for statistical analysis. TWIST1* represents mouse homologous of wildtype, S123A, R118H, T121E; S123E, T148A, A152P or I156N variants.
Scratch Assay
TWIST1*-CC155 (1 ug) and TCF12-CrN173 (1 ug) was co-transfected into C3H10T1/2 cells in 6-well pates. 24 hours after transfection, when cells had reached confluency, a p200 pipet tip was used to make a scratch on the cell monolayer. Plate was washed once with cell culture medium to remove floating cells after the scratch. Meanwhile Cell Observer Widefield microscope (ZEISS international) was equilibrated to normal cell culture conditions (37°C, 5% CO2). After plate was installed, bright-field images were taken at pre-set tile regions covering the scratch every 15 mins over a 12 hours' period. ImageJ was used to process the image data.
Essentially, the original image was enhanced by subtracting background and binary images were created to assist quantification of the gap closure. Total migration area from start of imaging until the time point when the first cell line closed gap was calculated. One-way ANOVA followed by wo-tailed t-test was used to determine the significance of difference between groups. 
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